These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet].
    Author: Chen YH, Yuan L, Chen YY, Qi CJ.
    Journal: Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):197-201. PubMed ID: 18785501.
    Abstract:
    OBJECTIVE: To observe the relationship between liver steatosis in rats with long-term high-caloric and high-fat diet and the expression of angiotensinogen (AGT), uncoupling protein 2 (UCP-2) and transforming growth factor beta1 (TGFbeta1). Then angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor blocker (ARB) drugs were given to investigate whether rennin-angiotensin system (RAS) blockade can mitigate the liver steatosis and to probe its mechanisms. METHODS: Forty male Wistar rats were divided into normal control group (NC group, n = 10), high-calorie and high-fat fed group (HF group, n = 10), ARB treated group (AR group, n = 10) and ACEI treated group (AE group, n = 10). Rats were fed with high-calorie and high-fat diet and given RAS inhibitor drugs (valsartan 40 mg/kg to the AR group and perindopril 4 mg/kg to the AE group) for eight weeks. Serum TG, free fatty acids (FFAs) lever and the fat content in liver were then measured with biochemical tests; insulin resistance was evaluated with euglycemic hyperinsulinemia clamp technique, the expression of UCP-2 and TGFbeta1 in liver tissue were examined with immunohistochemical staining and AGT mRNA, UCP-2 mRNA and TGFbeta1 mRNA were tested with RT-PCR. RESULTS: With the administration of RAS inhibitor drugs, following changes were observed. The levels of TG and FFAs and the fat content in liver decreased (P < 0.01 or P < 0.05), insulin resistance in high-fat fed rats was improved (P < 0.05), liver steatosis, inflammation and fibrosis were mitigated. The levels of UCP-2 decreased by 36.5% (P < 0.05) in AE group and 42.5% (P < 0.05) in AR group and TGFbeta1 decreased by 37% (P < 0.05) in AE group and 41.6% (P < 0.05) in AR group as compared with the HF group with immunohistochemical staining. The expression of AGTmRNA decreased by 14.9% (P < 0.05) in AE group and 21% (P < 0 .05) in AR group, UCP-2 mRNA decreased by 9% (P < 0.05) in AE group and 11% (P < 0.05) in AR group and TGFbeta1 mRNA decreased by 17% (P < 0.05) in AE group and 19% (P < 0.05) in AR group as compared with the HF group with RT-PCR. CONCLUSIONS: RAS blockade could improve insulin resistance, mitigate the liver injury of long term high-fat fed rats and have a protective effect on liver. The mechanism may be associated with the effects of improved insulin resistance, the interaction within RAS and the down-regulation of UCP-2 and TGFbeta1 in liver tissue.
    [Abstract] [Full Text] [Related] [New Search]